NCT00797797

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran When Added to Pregabalin in the Treatment of Fibromyalgia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 364 (actual)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.

Conditions

• Fibromyalgia

Interventions

Type	Name	Description
DRUG	No Treatment Added	No added treatment
DRUG	Milnacipran Added	Milnacipran 100 mg/d added

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-11-01
• Completion: 2010-01-01
• First posted: 2008-11-25
• Last updated: 2011-02-16
• Results posted: 2011-02-16

Locations

60 sites across 1 country: United States